Faes Farma SA Total Liabilities
Faes Farma SA total liabilities. Based on the latest financial reports, Faes Farma SA (FAE) has total liabilities worth €664.48 Million EUR (≈ $776.84 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check FAE financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Faes Farma SA (2000–2025)
Total liabilities of Faes Farma SA from 2000 to 2025. This chart illustrates how Faes Farma SA's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Faes Farma SA to see how much of total assets are deployed in long-term investments.
Faes Farma SA Competitors by Total Liabilities
The table below lists competitors of Faes Farma SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros
MC:LDA
|
Spain | €1.04 Billion |
|
Natural Resource Partners LP
NYSE:NRP
|
USA | $139.12 Million |
|
World Kinect Corporation
NYSE:WKC
|
USA | $5.59 Billion |
|
The Jammu & Kashmir Bank Limited
NSE:J&KBANK
|
India | Rs1.72 Trillion |
|
Liontown Resources Ltd
AU:LTR
|
Australia | AU$1.10 Billion |
|
Jinan Acetate Chemical Co Ltd
TW:4763
|
Taiwan | NT$4.50 Billion |
|
Golden Ocean Group Limited
F:KT31
|
Germany | €1.57 Billion |
|
Schrodinger Inc
NASDAQ:SDGR
|
USA | $311.44 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Faes Farma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Faes Farma SA.
Liquidity & Leverage Metrics
Faes Farma SA Total Liabilities Ratios Explained
Faes Farma SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Faes Farma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Faes Farma SA (2000–2025)
The table below shows the annual total liabilities of Faes Farma SA from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €594.19 Million ≈ $694.67 Million |
+369.85% |
| 2024-12-31 | €126.46 Million ≈ $147.85 Million |
+12.23% |
| 2023-12-31 | €112.68 Million ≈ $131.73 Million |
-8.68% |
| 2022-12-31 | €123.39 Million ≈ $144.26 Million |
+18.99% |
| 2021-12-31 | €103.70 Million ≈ $121.23 Million |
+13.61% |
| 2020-12-31 | €91.27 Million ≈ $106.71 Million |
+14.06% |
| 2019-12-31 | €80.02 Million ≈ $93.55 Million |
-33.68% |
| 2018-12-31 | €120.65 Million ≈ $141.05 Million |
+10.22% |
| 2017-12-31 | €109.47 Million ≈ $127.98 Million |
+136.25% |
| 2016-12-31 | €46.34 Million ≈ $54.17 Million |
+27.50% |
| 2015-12-31 | €36.34 Million ≈ $42.49 Million |
-5.87% |
| 2014-12-31 | €38.61 Million ≈ $45.14 Million |
-55.80% |
| 2013-12-31 | €87.35 Million ≈ $102.12 Million |
-14.39% |
| 2012-12-31 | €102.03 Million ≈ $119.28 Million |
-17.39% |
| 2011-12-31 | €123.51 Million ≈ $144.39 Million |
-6.14% |
| 2010-12-31 | €131.59 Million ≈ $153.84 Million |
+16.41% |
| 2009-12-31 | €113.04 Million ≈ $132.15 Million |
-4.45% |
| 2008-12-31 | €118.31 Million ≈ $138.31 Million |
-2.53% |
| 2007-12-31 | €121.38 Million ≈ $141.90 Million |
+31.10% |
| 2006-12-31 | €92.58 Million ≈ $108.24 Million |
+9.67% |
| 2005-12-31 | €84.42 Million ≈ $98.69 Million |
+22.55% |
| 2004-12-31 | €68.89 Million ≈ $80.53 Million |
-14.05% |
| 2003-12-31 | €80.15 Million ≈ $93.70 Million |
+17.00% |
| 2002-12-31 | €68.50 Million ≈ $80.08 Million |
-99.08% |
| 2001-12-31 | €7.47 Billion ≈ $8.74 Billion |
+8.06% |
| 2000-12-31 | €6.91 Billion ≈ $8.08 Billion |
-- |
About Faes Farma SA
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants servic… Read more